Cited In for PMID: 25634555

Year	Number of Results
2015	7
2016	20
2017	14
2018	10
2019	12
2020	14
2021	12
2022	1
2023	12
2024	2

1

Genetic advances in sarcomeric cardiomyopathies: state of the art.

Ho CY, Charron P, Richard P, Girolami F, Van Spaendonck-Zwarts KY, Pinto Y. Ho CY, et al. Cardiovasc Res. 2015 Apr 1;105(4):397-408. doi: 10.1093/cvr/cvv025. Epub 2015 Jan 29. Cardiovasc Res. 2015. PMID: 25634555 Free PMC article. Review.

2

Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future.

Abbas MT, Baba Ali N, Farina JM, Mahmoud AK, Pereyra M, Scalia IG, Kamel MA, Barry T, Lester SJ, Cannan CR, Mital R, Wilansky S, Freeman WK, Chao CJ, Alsidawi S, Ayoub C, Arsanjani R. Abbas MT, et al. Biomedicines. 2024 Mar 19;12(3):682. doi: 10.3390/biomedicines12030682. Biomedicines. 2024. PMID: 38540296 Free PMC article. Review.

3

Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitors.

Wijnker PJM, Dinani R, van der Laan NC, Algül S, Knollmann BC, Verkerk AO, Remme CA, Zuurbier CJ, Kuster DWD, van der Velden J. Wijnker PJM, et al. Cardiovasc Res. 2024 Mar 14;120(3):301-317. doi: 10.1093/cvr/cvae004. Cardiovasc Res. 2024. PMID: 38240646 Free PMC article.

4

ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation.

Fujiwara Y, Miki K, Deguchi K, Naka Y, Sasaki M, Sakoda A, Narita M, Imaichi S, Sugo T, Funakoshi S, Nishimoto T, Imahashi K, Yoshida Y. Fujiwara Y, et al. Stem Cell Reports. 2023 Nov 14;18(11):2108-2122. doi: 10.1016/j.stemcr.2023.09.003. Epub 2023 Oct 5. Stem Cell Reports. 2023. PMID: 37802074 Free PMC article.

5

Nucleus Mechanosensing in Cardiomyocytes.

Coscarella IL, Landim-Vieira M, Rastegarpouyani H, Chase PB, Irianto J, Pinto JR. Coscarella IL, et al. Int J Mol Sci. 2023 Aug 28;24(17):13341. doi: 10.3390/ijms241713341. Int J Mol Sci. 2023. PMID: 37686151 Free PMC article. Review.

6

Novel Therapeutic Avenues for Hypertrophic Cardiomyopathy.

Patil D, Bhatt LK. Patil D, et al. Am J Cardiovasc Drugs. 2023 Nov;23(6):623-640. doi: 10.1007/s40256-023-00609-1. Epub 2023 Sep 5. Am J Cardiovasc Drugs. 2023. PMID: 37670168 Review.

7

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy.

Garmany R, Bos JM, Dasari S, Johnson KL, Tester DJ, Giudicessi JR, Dos Remedios C, Maleszewski JJ, Ommen SR, Dearani JA, Ackerman MJ. Garmany R, et al. Sci Rep. 2023 Sep 1;13(1):14341. doi: 10.1038/s41598-023-40795-1. Sci Rep. 2023. PMID: 37658118 Free PMC article.

8

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy.

Doh CY, Kampourakis T, Campbell KS, Stelzer JE. Doh CY, et al. Front Cardiovasc Med. 2023 Aug 1;10:1238515. doi: 10.3389/fcvm.2023.1238515. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37600050 Free PMC article. Review.

9

A Family with Myh7 Mutation and Different Forms of Cardiomyopathies.

Catrina BI, Batar F, Baltat G, Bitea CI, Puia A, Stoia O, Fleacă SR, Teodoru M. Catrina BI, et al. Biomedicines. 2023 Jul 22;11(7):2065. doi: 10.3390/biomedicines11072065. Biomedicines. 2023. PMID: 37509704 Free PMC article.

10

Role of non-coding variants in cardiovascular disease.

Heshmatzad K, Naderi N, Maleki M, Abbasi S, Ghasemi S, Ashrafi N, Fazelifar AF, Mahdavi M, Kalayinia S. Heshmatzad K, et al. J Cell Mol Med. 2023 Jun;27(12):1621-1636. doi: 10.1111/jcmm.17762. Epub 2023 May 15. J Cell Mol Med. 2023. PMID: 37183561 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year